|
US4942156A
|
|
Low molecular weight heparin derivatives having improved anti-Xa specificity
|
|
US4757056A
|
|
Method for tumor regression in rats, mice and hamsters using hexuronyl hexosaminoglycan-containing compositions
|
|
EP0091196A1
|
|
Adrenosteroid composition
|
|
ZA8209463B
|
|
Process for manufacturing low molecular weight heparins by depolymerization of normal heparin
|
|
JPS56120704A
|
|
Method of obtaining low molecular weight heparin having heightened pharmacologic property* product manufactured thereby and its use
|
|
US4281108A
|
|
Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
|
